Genetic and pharmacological inhibition of dihydroorotate dehydrogenase suppressed the proliferation and tumorigenicity of MYCN-amplified neuroblastoma cell lines.
[Cell Death & Disease]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Neural Cell News Therapeutic Targeting of Both Dihydroorotate Dehydrogenase and Nucleoside Transport in MYCN-Amplified Neuroblastoma
